AU7373600A - Method of potentiating chemotherapy and treating solid tumors - Google Patents

Method of potentiating chemotherapy and treating solid tumors

Info

Publication number
AU7373600A
AU7373600A AU73736/00A AU7373600A AU7373600A AU 7373600 A AU7373600 A AU 7373600A AU 73736/00 A AU73736/00 A AU 73736/00A AU 7373600 A AU7373600 A AU 7373600A AU 7373600 A AU7373600 A AU 7373600A
Authority
AU
Australia
Prior art keywords
solid tumors
treating solid
potentiating
chemotherapy
potentiating chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73736/00A
Inventor
Gary Dukart
James Joseph Gibbons
Judy Lucas
Lisa Anne Speicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU7373600A publication Critical patent/AU7373600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU73736/00A 1999-09-15 2000-09-12 Method of potentiating chemotherapy and treating solid tumors Abandoned AU7373600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39605199A 1999-09-15 1999-09-15
US09396051 1999-09-15
PCT/US2000/025008 WO2001019399A2 (en) 1999-09-15 2000-09-12 Method of potentiating chemotherapy and treating solid tumors

Publications (1)

Publication Number Publication Date
AU7373600A true AU7373600A (en) 2001-04-17

Family

ID=23565645

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73736/00A Abandoned AU7373600A (en) 1999-09-15 2000-09-12 Method of potentiating chemotherapy and treating solid tumors

Country Status (8)

Country Link
EP (1) EP1214092A2 (en)
JP (1) JP2003509383A (en)
CN (1) CN1391484A (en)
AR (1) AR025659A1 (en)
AU (1) AU7373600A (en)
BR (1) BR0014001A (en)
CA (1) CA2381078A1 (en)
WO (1) WO2001019399A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010401A (en) * 2001-05-16 2004-03-09 Novartis Ag Combination comprising n-{5 -[4-(4-methyl -piperazino -methyl)-benzoylamido] -2-methylphenyl} -4-(3-pyridyl) -2pyrimidine -amine and a chemotherapeutic agent.
CN109601739B (en) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 Compound amino acid feed additive and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042116A1 (en) * 1998-02-24 1999-08-26 Dovetail Technologies Inc. Novel disulfides and thiol compounds
JP2002533387A (en) * 1998-12-23 2002-10-08 ジー．ディー．サール ＆ カンパニー Use of integrin antagonists and one or more antitumor agents as combination therapy for tumor treatment

Also Published As

Publication number Publication date
WO2001019399A2 (en) 2001-03-22
CA2381078A1 (en) 2001-03-22
CN1391484A (en) 2003-01-15
EP1214092A2 (en) 2002-06-19
BR0014001A (en) 2002-05-21
WO2001019399A3 (en) 2001-12-13
AR025659A1 (en) 2002-12-11
JP2003509383A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
AU4564200A (en) Method for treating cancer using camptothecin derivatives and 5-fluorouracil
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU6492600A (en) Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2212299A (en) Compositions and methods for the treatment of tumor
HUP0201436A2 (en) Methods and compositions for treating solid tumors
EP1176964B8 (en) Uses of et743 for treating cancer
AU7360000A (en) Methods and compositions for preventing and treating prostate disorders
AU2001253836A1 (en) Method of treating cancer
AU7350500A (en) Method and formula for tumor remission and suppression of cancer
AU7363000A (en) Method for reducing the risk of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU7373600A (en) Method of potentiating chemotherapy and treating solid tumors
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU5369498A (en) Compounds and methods for treating cancer
AU4985200A (en) Methods of treating hypertension
AU5097099A (en) Methods and compositions for cancer treatment
AU2390700A (en) Polypeptidic compositions and methods for the treatment of tumors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase